Roche Bumps Illumina Cash Offer Up To $6.5B

Law360, New York (March 29, 2012, 3:19 PM EDT) -- Roche Holding AG has boosted its offer to buy gene-sequencing company Illumina Inc. to $51 per share — more than $6.5 billion overall — in an appeal to get company leaders and shareholders to sign off on the hostile takeover, Roche announced Thursday.

The new offer, a 15 percent premium on the original $44.50-per-share price laid out in January, hikes up Illumina's valuation from $5.7 billion, answering Illumina shareholders' requests to speed up the deal, Roche CEO Severin Schwan said.

“We have seen interest to accelerate...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.